Back to results
UnknownN/A

Evaluation of Response to Two Schedules of Capecitabine in Patients With Metastatic Breast Cancer

NCT02028494

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

SLACOM

Buenos Aires, Argentina

Contact

Daniel Campos, MD

+5491144204242dcampos@slacom.org
View on ClinicalTrials.gov
Evaluation of Response to Two Schedules of Capecitabine in Patients With Metastatic Breast Cancer — TrialFind